1. 1) Remy S, Beck H. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain, 129, 18–35 (2006).
2. 2) Granata T, Marchi N, Carlton E, Ghosh C, Gonzalez-Martinez J, Alexopoulos AV, Janigro D. Management of the patient with medically refractory epilepsy. Expert Rev. Neurother., 9, 1791–1802 (2009).
3. 3) Dalkara S, Karakurt A. Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders. Curr. Top. Med. Chem., 12, 1033–1071 (2012).
4. 4) Spinella M. Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav., 2, 524–532 (2001).
5. 5) Liu GQ, Sun JN, He ZZ, Jiang Y. Spasmolytic actions of active principles of volatile of Acorus gramineus (Chinese). Acta Pharmacol. Sin., 4, 95–97 (1983).